NCT00241358 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- * Day 1: Mobilization with 240 mcg/kg SC AMD3100 and leukopheresis * If PBSC collected are not adequate, then donor will again be mobilized with AMD3100 and have leukopheresis collection on day 3.
- id
- FG000
- title
- Subcutaneous (SC) Treatment Plan - Donor
- description
- * Conditioning Regimen * Cyclophosphamide 60mg/kg/day on Days -3 and -2 * TBI 550cGy on Day -1 * GVHD prophylaxis \*Cyclosporin 3.0mg/kg/day beginning on Day -1 then tapered through Day +100 * PBSC transplant on Day 0
- id
- FG001
- title
- Recipients
- description
- * Day -3: Mobilization with 80-480 mcg/kg/day IV AMD3100 and PK analysis * Day 1: Mobilization with 240 mcg/kg/day SC AMD3100 and leukopheresis * If PBSC collected are not adequate, then donor will again be mobilized with AMD3100 and have leukopheresis collection on day 3.
- id
- FG002
- title
- Intravenous (IV) Treatment Plan - Donor
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 1
- type
- Determined to be not ineligible
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 25
- group Id
- FG001
- num Subjects
- 46
- group Id
- FG002
- num Subjects
- 21
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 25
- group Id
- FG001
- num Subjects
- 45
- group Id
- FG002
- num Subjects
- 20
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 1
- type
- NOT COMPLETED
- title
- Overall Study
- recruitment Details
- The study was opened to participant enrollment on 05/14/2004 and closed to participant enrollment on 01/26/2009.
Complete source fields
- groups
- description
- * Day 1: Mobilization with 240 mcg/kg SC AMD3100 and leukopheresis * If PBSC collected are not adequate, then donor will again be mobilized with AMD3100 and have leukopheresis collection on day 3.
- id
- FG000
- title
- Subcutaneous (SC) Treatment Plan - Donor
- description
- * Conditioning Regimen * Cyclophosphamide 60mg/kg/day on Days -3 and -2 * TBI 550cGy on Day -1 * GVHD prophylaxis \*Cyclosporin 3.0mg/kg/day beginning on Day -1 then tapered through Day +100 * PBSC transplant on Day 0
- id
- FG001
- title
- Recipients
- description
- * Day -3: Mobilization with 80-480 mcg/kg/day IV AMD3100 and PK analysis * Day 1: Mobilization with 240 mcg/kg/day SC AMD3100 and leukopheresis * If PBSC collected are not adequate, then donor will again be mobilized with AMD3100 and have leukopheresis collection on day 3.
- id
- FG002
- title
- Intravenous (IV) Treatment Plan - Donor
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 1
- type
- Determined to be not ineligible
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 25
- group Id
- FG001
- num Subjects
- 46
- group Id
- FG002
- num Subjects
- 21
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 25
- group Id
- FG001
- num Subjects
- 45
- group Id
- FG002
- num Subjects
- 20
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 1
- type
- NOT COMPLETED
- title
- Overall Study
- recruitment Details
- The study was opened to participant enrollment on 05/14/2004 and closed to participant enrollment on 01/26/2009.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle